Data as of .
FMED vs GDOC: which is really different?
FMED and GDOC hold 24% of their weight in the same names, and FMED returned more over the year.
ETFIQ Off-Index Score: FMED scores higher
How much of it is not the index it is sold as an alternative to?
A percentile among the 379 thematic ETFs with a holdings filing. It is a position in a set, not a rating, and neither end of it is a recommendation. All thematic ETFs ranked by it · How it is computed
24% of the two portfolios are the same securities at the same weight.
What they hold in common
By the books each fund has filed, FMED and GDOC hold 24% of their money in the same securities at the same weight.
| Holding | FMED | GDOC |
|---|---|---|
| INTUITIVE SURGICAL INC | 2.93% | 3.96% |
| ARGENX SE | 2.79% | 4.13% |
| EDWARDS LIFESCIENCES CORP | 2.12% | 3.03% |
| THERMO FISHER SCIENTIFIC INC | 1.54% | 4.59% |
| BOSTON SCIENTIFIC CORP | 1.44% | 3.84% |
| CYTOKINETICS INC | 1.55% | 1.42% |
| GUARDANT HEALTH INC | 1.39% | 5.42% |
| XENON PHARMACEUTICALS INC | 1.92% | 1.38% |
| UNITEDHEALTH GROUP INC | 2.26% | 1.37% |
| LONZA GROUP AG | 1.22% | 2.84% |
| DEXCOM INC | 1.18% | 2.84% |
| INSMED INC | 1.80% | 1.12% |
| Only in FMED | Only in GDOC |
|---|---|
| UCB SA 4.75% | JOHNSON & JOHNSON 8.19% |
| LIFESTANCE HEALTH GROUP INC 4.29% | MERCK & COMPANY INC 6.04% |
| DANAHER CORP 3.43% | ASTRAZENECA PLC 4.92% |
| 10X GENOMICS INC 3.12% | HOYA CORP 3.58% |
| COGENT BIOSCIENCES INC 2.86% | AGILENT TECHNOLOGIES INC 2.81% |
| ALNYLAM PHARMACEUTICALS INC 2.80% | CENCORA INC 2.38% |
| LEGEND BIOTECH CORP 2.30% | APOGEE THERAPEUTICS INC 2.00% |
| BIO TECHNE CORP 2.25% | ROYALTY PHARMA PLC 1.79% |
Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated May 31, 2026.
Performance, window by window
| Window | Total return | vs the S&P 500 | vs the Nasdaq-100 | |||
|---|---|---|---|---|---|---|
| FMED | GDOC | FMED | GDOC | FMED | GDOC | |
| 3 months | +21.3% | +11.7% | +19.0 pts | +9.5 pts | +23.7 pts | +14.2 pts |
| 6 months | +32.3% | +16.6% | +14.3 pts | −1.4 pts | +8.0 pts | −7.6 pts |
| 1 year | +28.3% | +13.9% | +11.7 pts | −2.6 pts | +6.5 pts | −7.8 pts |
| 3 years | +39.6% | +19.5% | −38.8 pts | −58.9 pts | −58.5 pts | −78.7 pts |
| Since launch | +25.8% | −4.3% | −57.6 pts | −79.9 pts | −78.1 pts | −94.4 pts |
| FMED Fidelity Disruptive Medicine ETF Holds 68 stocks in broad innovation and megatrends, 25% of its weight in S&P 500 companies | GDOC Goldman Sachs Future Health Care Equity ETF Holds 41 stocks in broad innovation and megatrends, 57% of its weight in S&P 500 companies | |
|---|---|---|
| Issuer | Fidelity | Goldman Sachs |
| Theme | Broad innovation and megatrends | Broad innovation and megatrends |
| In the S&P 500 | 25.4% | 56.7% |
| Active share vs the S&P 500 | 97.1% | 95.3% |
| In the Nasdaq-100 | 8.7% | 9.4% |
| Holdings | 68 | 41 |
| Top ten, share of the fund | 31.5% | 58.2% |
| Expense ratio | 0.50% | 0.75% |
| Fee for the differing part | 0.51% | 0.79% |
| Total return, 1 year | +28.3% | +13.9% |
| vs the S&P 500 | +11.7 pts | −2.6 pts |
| vs the Nasdaq-100 | +6.5 pts | −7.8 pts |
| Below its high | −3.8% | −4.5% |
| Net assets | $52m | $19m |
FMED in plain words
By weight, 25% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 97%. The top ten holdings are 32% of the fund across 68 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +28.3% with distributions reinvested against +16.6% for the S&P 500, so a holder was ahead by 11.7 pts.
GDOC in plain words
By weight, 57% of GDOC's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 95%. The top ten holdings are 58% of the fund across 41 positions, as filed for May 31, 2026. Over the year to Sep 18, 2026 the fund returned +13.9% with distributions reinvested against +16.6% for the S&P 500, so a holder was behind by 2.6 pts.
Questions people ask
- Do FMED and GDOC hold the same stocks?
- By their latest filings, 24% of their books are the same securities at the same weight, which is a meaningful overlap. Overlap is the sum of the smaller weight of every security they share.
- Which is more different from the S&P 500, FMED or GDOC?
- FMED has 25% of its weight in S&P 500 names and GDOC has 57%, so FMED differs more from the index.
- Which is cheaper, FMED or GDOC?
- FMED charges 0.50% a year and GDOC charges 0.75%, so FMED is cheaper. Fees come from each fund's prospectus.
Other comparisons
Where these figures came from
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.
Cite this page. ETFIQ, FMED against GDOC, data as of Sep 18, 2026. https://etfiq.com/compare/themes/fmed-vs-gdoc Free to use with attribution; the underlying files are at Open data.